Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination [NA]

View source ↗

Summary

A clinical trial protocol evaluating safety and immune responses to sequential administration of the 9-valent HPV vaccine for cervical cancer prevention; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Cervical Cancer Prevention | NA | Status: NOT_YET_RECRUITING